License plates of MIT
Custom plates display expressions of scholarship, creativity, and MIT pride among Institute affiliates.
Custom plates display expressions of scholarship, creativity, and MIT pride among Institute affiliates.
With their “T-REX” method, DNA embedded in the polymer could be used for long-term storage of genomes or digital data such as photos and music.
By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.
MIT researchers plan to search for proteins that could be used to measure electrical activity in the brain.
A catalyst tethered by DNA boosts the efficiency of the electrochemical conversion of CO2 to CO, a building block for many chemical compounds.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.
By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.
MIT study suggests 3D folding of the genome is key to cells’ ability to store and pass on “memories” of which genes they should express.
MIT computer scientists developed a way to calculate polygenic scores that makes them more accurate for people across diverse ancestries.
New research finds RNA-guided enzymes called Fanzors are widespread among eukaryotic organisms.
By analyzing epigenomic and gene expression changes that occur in Alzheimer’s disease, researchers identify cellular pathways that could become new drug targets.
The findings could help doctors identify cancer patients who would benefit the most from drugs called checkpoint blockade inhibitors.